Finance

Lists
Q1 2027 earnings • in 2 days
See details
3349:TYO
Cosmos Pharmaceutical Corp
6 392,00 JP¥
+0,52%
(+33,00) 1D
9 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 3349...
Open
6 405 JP¥
High
6 434 JP¥
Low
6 318 JP¥
Mkt. cap
511,37 մլրդ
Avg. vol.
436,18 հզր
Volume
317,90 հզր
Dividend
1,28%
Quarterly dividend
21 JP¥
Ex-dividend date
27 նոյ, 2026 թ.
P/E ratio
15,81
52-wk high
8 590 JP¥
52-wk low
5 615 JP¥
EPS
404 JP¥
Shares outstanding
19,80 մլն
No. of employees
6 հզր
Open
6 405 JP¥
High
6 434 JP¥
Low
6 318 JP¥
Mkt. cap
511,37 մլրդ
Avg. vol.
436,18 հզր
Volume
317,90 հզր
Dividend
1,28%
Quarterly dividend
21 JP¥
Ex-dividend date
27 նոյ, 2026 թ.
P/E ratio
15,81
52-wk high
8 590 JP¥
52-wk low
5 615 JP¥
EPS
404 JP¥
Shares outstanding
19,80 մլն
No. of employees
6 հզր
News stories
From web sources and news partners
About Cosmos Pharmaceutical Corp
CEO-
Employees5,98 հզր
Foundedդեկ 1983
Headquarters-
SectorDrug
Websitecosmospc.co.jp
Next call in 39:34:23
հոկ 13, երք, 00:00
Fiscal period
Q1 2027
- / -
Revenue / Est. (JPY)
- / 291,21 մլրդ
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. օգս
2025 թ. նոյ
2026 թ. փտվ
2026 թ. մյս
Revenue
272,39 մլրդ
264,78 մլրդ
273,20 մլրդ
289,20 մլրդ
Cost of goods sold
215,22 մլրդ
209,07 մլրդ
216,15 մլրդ
229,46 մլրդ
Cost of revenue
215,22 մլրդ
209,07 մլրդ
216,15 մլրդ
229,46 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45,64 մլրդ
46,57 մլրդ
45,83 մլրդ
26,43 մլրդ
Operating expense
45,64 մլրդ
46,57 մլրդ
45,83 մլրդ
49,08 մլրդ
Total operating expenses
260,86 մլրդ
255,64 մլրդ
261,97 մլրդ
278,54 մլրդ
Operating income
11,54 մլրդ
9,14 մլրդ
11,23 մլրդ
10,66 մլրդ
Other non operating income
627,00 մլն
801,00 մլն
667,00 մլն
695,00 մլն
EBT including unusual items
12,09 մլրդ
9,58 մլրդ
11,96 մլրդ
10,60 մլրդ
EBT excluding unusual items
12,08 մլրդ
9,85 մլրդ
11,81 մլրդ
11,12 մլրդ
Income tax expense
3,92 մլրդ
3,10 մլրդ
3,86 մլրդ
1,30 մլրդ
Effective tax rate
32,40%
32,35%
32,26%
12,26%
Other operating expenses
-
-
-
-
Net income
8,17 մլրդ
6,48 մլրդ
8,10 մլրդ
9,30 մլրդ
Net profit margin
3,00%
2,45%
2,96%
3,21%
Earnings per share
-
-
-
-
Interest and investment income
27,00 մլն
19,00 մլն
16,00 մլն
12,00 մլն
Interest expense
-110,00 մլն
-107,00 մլն
-107,00 մլն
-257,00 մլն
Net interest expenses
-83,00 մլն
-88,00 մլն
-91,00 մլն
-245,00 մլն
Depreciation and amortization charges
-
-
-
22,64 մլրդ
EBITDA
17,09 մլրդ
15,00 մլրդ
16,79 մլրդ
16,81 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps